Connor, Clark & Lunn Investment Management Ltd. Tandem Diabetes Care Inc Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 272,097 shares of TNDM stock, worth $8.98 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
272,097
Previous 205,410
32.47%
Holding current value
$8.98 Million
Previous $8.28 Million
39.41%
% of portfolio
0.06%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding TNDM
# of Institutions
361Shares Held
72.5MCall Options Held
3.36MPut Options Held
229K-
Black Rock Inc. New York, NY11.1MShares$367 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.36MShares$243 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.27MShares$108 Million0.02% of portfolio
-
State Street Corp Boston, MA2.66MShares$87.6 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.39MShares$78.8 Million1.44% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $2.12B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...